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Abstract
Percutaneous intervention is one treatment option for symptomatic
hepatic hemangioma in infants. We report the case of a newborn
(birth weight 4060 g) with a large hepatic cavernous hemangioma,
which presented early with high cardiac output failure due to
arteriovenous shunting and signs of incipient Kasabach-Merritt
syndrome. We performed a successful superselective transcatheter
coil embolization of three feeding arteries on the seventh day of
life. Because of remaining diffuse very small arteries causing a
relevant residual shunt, additional occlusion of the three main
draining veins was necessary with three Amplatzer vascular plugs.
Cardiac failure resolved immediately. Without any additional
therapy the large venous cavities disappeared within the following
months. The tumor continues to regress in size 8 months after the
intervention.
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Infantile hepatic hemangiomas are frequent. Mostly they are
diagnosed within the first 6 months of life. Clinical manifestations
can be heart failure due to a relevant left-to-right shunt with
tachydyspnea, liver enlargement, consumption coagulopathy with
anemia and thrombopenia (Kasabach-Merritt syndrome), and
cutaneous hemangioma [1–3]. The diagnostic modalities com-
monly used are ultrasonography, with computed tomography (CT)
or magnetic resonance imaging (MRI). Treatment strategies in-
clude medical and surgical options, as well as an interventional
approach, and depend on tumor size, growth characteristics, loca-
tion, and complications [1–8]. Established medical treatment
consists of steroids and interferon-alpha [1, 2, 4, 5]. Surgically,
arterial feeding vessels may be ligated, hemangiomas can be re-
sected and, in severe cases, liver transplantation is possible [1, 2, 3,
9].
In symptomatic patients, percutaneous catheter embolization
has been increasingly performed in recent years due to good
experiences, good results, and optimized endovascular techniques
[5–8]. Until now, in all reported cases of interventional treatment,
only embolizations of the arterial feeders, either with coils [5–7] or
with glue [8], have been described.
We report the case of a symptomatic male newborn with a large
cavernous hepatic hemangioma. He was admitted in high-output
cardiac failure due to the arteriovenous shunt with signs of incip-
ient Kasabach-Merritt syndrome. Coil embolization of the main
arterial feeders was not sufficient because of diffuse additional
smaller arterial vessels. To our knowledge, the additional suc-
cessful venous occlusion of the main draining veins in a newborn
has not previously been described. Furthermore, the Amplatzer
vascular plug (AGA Medical, Golden Valley, MN, USA), which
has recently been developed for closure of vascular abnormalities
[10], was used in this case for the first time for venous occlusion of
a hepatic hemangioma in a newborn.
Case Report
A newborn male at 40 weeks of gestation with a birth weight of 4060 g
developed unexplained mild cyanosis, massive edema especially in the
upper part of the body, and severe hypoglycemia during the first day of life.
Ultrasonography revealed a large mass of 6 cm · 6 cm · 6 cm within the
lower part of the right liver lobe with the appearance of a cavernous
hemangioma. The draining liver veins as well as the inferior caval vein
were extensively dilated. Radiography (Fig. 1(1)) showed a global
enlargement of the heart and dilatation of the central pulmonary arteries.
Subsequent echocardiography confirmed mild heart failure with right atrial
and ventricular dilatation, slightly reduced ventricular contractility, and
intermittent right-to-left shunting through a patent foramen ovale from
volume overload. Despite anticongestive therapy, tachypnea and cardiac
enlargement persisted. Furthermore the patient underwent intermittent
phototherapy for recurrent hyperbilirubinemia. MRI of the abdomen clearly
showed the large singular cavernous hemangioma in the right lower lobe of
the liver with dilatation of all liver veins (Fig. 2). Persisting cardiac failure
despite therapy and thrombocytopenia, which was interpreted as the signs
of incipient Kasabach-Merritt syndrome, motivated interventional cathe-
terization on the seventh day of life.
Catheterization took place with the patient under general anesthesia
using a 4 Fr sheath in the right femoral artery, and initially also a 4 Fr
sheath in the right femoral vein. Cefazolin was administered three times
within the first 24 hr, starting with the first dose during the procedure.
Standard right and left heart catheterization revealed the main pulmonary
artery pressure to be elevated to 38/16/25 mmHg, with a calculated
pulmonary-to-systemic flow ratio of 7.0. The descending aortogram
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demonstrated the arterial feeding vessels of the hepatic hemangioma,
arising mainly from the celiac trunk with additional diffuse small arteries
from the intercostal arteries (Fig. 3). The three main feeders were
reached with a guiding 4 Fr Right Coronary Amplatz Modified Super
Torque catheter (Cordis, Johnson & Johnson, Miami, FL, USA), and
selectively with a VASCO + 18 microcatheter (BALT, Montmorency,
France). They were uneventfully supraselectively embolized with 15
platinum embolization pushable coils (BALT, Montmorency, France) of
different sizes (2 to 3 mm) and lengths (50 to 80 mm). A repeat
angiogram demonstrated the complete closure of these vessels, but the
remaining smaller and diffuse arteries from the intercostal arteries still
provided a significant source of blood supply to the hepatic hemangioma.
It was not possible to close them because of their diffuse origins and
small vessel diameters.
Because of the insufficient result, an additional venous intervention
was considered. Therefore, the 4 Fr sheath in the femoral vein was ex-
changed for a 6 Fr Flexor Check-Flo Introducer sheath (Cook Medical,
Bloomington, IN, USA), which was placed in the right upper liver vein.
Selective angiography showed the cavernous venous part of the heman-
gioma and three main draining veins from the dilated liver veins (Fig. 4).
It was possible to reach each draining vein near its origin with the guiding
catheter, and to implant an 8 mm, 10 mm, and 12 mm Amplatzer Vas-
cular Plug, respectively. The plugs were attached to a nitinol pusher
delivery cable. The transfer through the sheath was easy, and the plugs
even tracked perfectly around the proximal sharp sheath curve (90–120).
After a test injection through the sheath, which confirmed the excellent
configuration and position of each device, the device was released by
unscrewing the delivery cable. Final arterial and venous angiograms
demonstrated clearly reduced arterial and venous flow through the hem-
angioma with slowed, but not completely interrupted, venous flow
through the wire mesh of the vascular plugs (Fig. 5). The pulmonary-to-
systemic flow ratio was diminished to 1.4. No procedure-related com-
plication occurred.
The patient improved quickly after the embolization, and was extubated
1 day after the intervention. Radiography demonstrated an immediate
reduction in size of the heart (Fig. 1 (2)). Pretreatment cardiac dilatation
and heart failure disappeared quickly. The serum aminotransferase levels,
which were initially elevated up to 1000 IU/l, normalized within days.
Platelet count and liver function improved, and no substitution of platelets
or fresh frozen plasma was necessary. Because of this good post-inter-
ventional result, treatment with corticosteroids or interferon-alpha was not
considered necessary for adjunctive therapy. The patient was discharged
home 12 days after the intervention with mild anticongestive treatment
(diuretics), and oral antiplatelet treatment with aspirin. Diuretics and aspirin
were continued for 12 weeks. Abdominal ultrasonography showed imme-
diate regression of the intrahepatic lesion. After 3 months, the cavernous
structures of the hemangioma were no longer detectable and the venous
Amplatzer plugs did not show any residual flow. Neurologic development
was normal, and there were no residual signs of heart failure over a follow-
up period of 8 months.
Fig. 2. MRI of the abdomen demonstrating the large singular ca-
vernous hemangioma in the right lower lobe of the liver with dilatation
of all liver veins.
Fig. 3. An angiogram in the descending thoracic/abdominal aorta
demonstrating multiple arterial feeding vessels of the hepatic he-
mangioma arising mainly from the celiac trunc and additionally with
diffuse small arteries from intercostal arteries.
Fig. 1. Chest X-ray (A) Cardiac and hepatic
enlargement before intervention. (B) Normalization
of cardiac enlargement 1 day after intervention.
Platinum embolization coils in arteries supplying
the hepatic hemangioma, mainly arising from the
coeliacal trunc, and 3 Amplatzer Vascular Plugs,
with a size of 8, 10 and 12 mm, respectively, in the
3 main draining intrahepatic vessels.
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Discussion
Neonatal intrahepatic hemangioma and arteriovenous malforma-
tions can cause early congestive heart failure by severe arteriove-
nous shunting. In the past, these patients have had to be treated
surgically [1, 2, 3, 9] by partial hepatectomy, ligation of the hepatic
artery, or even orthotopic liver transplantation in the neonatal
period. A developing alternative in these cases is therapeutic
selective interventional hepatic embolization of feeding arteries [1,
3, 5–8].
In asymptomatic patients, even a conservative approach without
any therapy can be considered because of the high possibility of
spontaneous regression within the first year of life [3].
There already exists good evidence from smaller patient groups
or case reports that drug therapy, alone or together with surgery, or
intervention with corticosteroids and/or interferon-alpha may
efficiently reduce the volume of a hemangioma [1–5, 7, 9].
The results of interventional therapy in patients in whom
medical therapy has failed or the symptoms of cardiac failure are
rapidly progressive, are mainly encouraging. Symptoms leading to
an interventional approach are heart failure, consumptive coagul-
opathy (Kasabach-Merritt syndrome), anemia, abdominal mass,
and respiratory distress requiring mechanical ventilation [1, 3, 5–
8]. Selective embolization of the feeding arteries can be achieved
using small flexible target or detachable coils [1, 3, 5–7]. The use
of a mixture of lipiodol and Histoacryl glue for smaller arteries has
been described with good results in 2 patients [8]. Sometimes even
after an obviously successful embolization, ‘‘residual’’ arterial
perfusion of the tumor can be shown immediately after coil
occlusion. The vascular supply may arise not only from hepatic
artery branches, but also from extrahepatic collaterals from the
superior mesenteric artery, intercostals, phrenic and adrenal
arteries, and from portal veins [7, 8]. If these residual collaterals
do not cause further hyperperfusion with congestive heart
failure, there is no need to occlude them, because they will
probably regress within months [7]. Otherwise, the tumor may
also be surgically resected after cardiopulmonary stabilization,
allowing improved operability.
Our patient presented with signs of cardiac failure due to
arteriovenous shunting (pulmonary-to-systemic flow ratio of 7.0),
the signs of incipient consumptive coagulopathy, and liver
insufficiency. Therefore, the interventional approach was indi-
cated. We also saw a multifocal vascular supply to the cavernous
hemangioma. Though the main feeding arteries arising from the
hepatic artery could be selectively coil embolized, the remaining
smaller collaterals, mainly from intercostal arteries, were
responsible for continuing and hemodynamically relevant arte-
riovenous shunting. An additional venous approach with occlu-
sion of the main draining intrahepatic veins near their origins
from the tumor was successfully performed with three Amplatzer
vascular plugs. Cardiac failure resolved immediately within the
first days after the intervention, and the intrahepatic lesion con-
tinued to regress.
We used the Amplatzer vascular plug for this novel approach
both because it is a new device specific for vessel occlusion, and
for its extremely user-friendly simple mechanics. The self-
expandable cylindrical nitinol device is attached to a flexible
nitinol delivery cable and comes preloaded in a loader. In case of
unsatisfactory positioning, the device can easily be retrieved with
this cable. As soon as the position is verified, the device can be
deployed by unscrewing it. With the above-mentioned character-
istics, its low profile, and an acceptable cost-effectiveness, the plug
has already been used to occlude most abnormal vessels [10].
Especially in aortico-pulmonary [10, 11] and veno-venous [10, 12]
collaterals, and in pulmonary arteriovenous fistulas [10, 13], it has
proven to be a suitable occlusion device. Hill et al. also describe
successful closure of a transhepatic access for cardiac catheteri-
zation in 7 patients with the Amplatzer vascular plug [10]. For the
closure of a patent ductus arteriosus, which has been carried out in
4 patients [10, 14], the larger pores of the larger devices may be
responsible for a residual shunt [10].
Fig. 4. A selective angiogram of the cavernous part of the he-
mangioma showing three main draining veins into the dilated liver
veins. Multiple embolization coils in the feeding arteries.
Fig. 5. A final angiogram in the descending aorta demonstrating a
clearly reduced arterial and venous flow through the hemangioma
and demonstrating the correct position and configuration of the
implanted coils and Amplatzer Vascular Plugs.
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In our case we needed a 6 Fr guiding sheath to implant the
vascular plugs of 8 mm, 10 mm, and 12 mm diameter. All devices
tracked easily around the proximal sharp sheath curve (90–120)
into their final intrahepatic position. Follow-up Doppler studies did
not show any occlusion of the femoral vessels. Following the
procedure, aspirin was used as an antiplatelet agent at a dose of 4
mg/kg per day for 3 months. This might be responsible for the open
femoral vessels, but it also probably delayed the complete closure
of the vascular plugs. Perhaps a shorter antiplatelet treatment
period of 4 weeks would have been sufficient.
To our knowledge this is the first description of an additional
venous closure in a symptomatic neonatal intrahepatic hemangi-
oma, as well as the first use of the Amplatzer vascular plug for this
condition.
As illustrated in the case, this combined interventional arterial
and venous approach can be a successful treatment option where
there is multifocal vessel supply to a symptomatic hepatic hem-
angioma, even in a newborn.
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